Pioneers of the first scalable "off the shelf" allogeneic gamma delta T cell therapy platform.
We are committed to bringing improved medicines to patients as quickly as possible by creating efficient product development and clinical translation processes. We retain in-house control of the critical elements of drug development. At our operational headquarters in the UK, a diverse team of interdisciplinary scientists are optimizing new product candidates in our new state-of-the-art research complex. Experienced, dedicated personnel are creating quality-controlled products in our GMP cell and gene manufacturing suites. Our clinical group are working directly with physicians and hospitals around the world.
We are developing safer, efficacious, cost-effective cell therapy products which can target more cancers and infectious disease and save more lives. Learn more about the history and mission of TC BioPharm.
